Malaysian Genomics Signs Agreement with National Institutes of Health to Explore Research Opportunities
PETALING JAYA, Malaysia, Oct 12, 2022 - (ACN Newswire via SEAPRWire.com) - MGRC Therapeutics Sdn Bhd (MGRC-T), a wholly-owned subsidiary of Malaysian Genomics Resource Centre Berhad (Bursa: MGRC, 0155), a leading genomics and biopharmaceutical specialist, has entered into a cooperation agreement with the National Institutes of Health, Malaysia (NIH), providing a framework for collaboration between the two parties in medical research pertaining to genomics and biopharmaceuticals.Dato' Alvin Joseph Nesakumar, Executive Director of Malaysian GenomicsThe National Institutes of Health (NIH), the research arm under the Ministry of Health Malaysia, comprises six research institutes that focus on biomedical research, public health and epidemiology, clinical research, behavioural health research, health management and health policies. The NIH is mandated to conduct high-impact health research to improve the quality of life of the Rakyat. The health research conducted by the NIH is in line with the Health Research Priority Areas for each five-yearly Malaysia Plans.MGRC-T specialises in genomics and biopharmaceutical services with proprietary know-how and intellectual property related to the ...
